Peer Review History

Original SubmissionOctober 4, 2023
Decision Letter - Gregory S. Barsh, Editor, Sean P. Curran, Editor

Dear Dr Dowen,

Thank you very much for submitting your Research Article entitled 'Kombucha Tea-associated Microbes Remodel Host Metabolic Pathways to Suppress Lipid Accumulation.' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript.

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.  Please note that several of comments from reviewers 1 and 2 only require modification of the text or toning down the interpretation of the results.  Please note the concerns raised by reviewer 3 that warrant detailed attention.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Sean P. Curran

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: In this manuscript, DuMez-Kornegay et al. characterize the utility of a C. elegans model system in studying the impact of kombucha-tea associated microbes (KTMs) on organismal physiology. The manuscript is very well-written and extremely easy to follow, and the thoroughness of the experimental methodology and data analysis is commendable. The data is quite strong and well-controlled, and the model system is very interesting. I have very few comments about the study, all of which can be addressed textually. While I recommend a few experiments, these are all merely suggestions as the rigor of the data is sufficient that new experiments do not need to be performed, although in some cases (if the authors find it helpful) may benefit the strength of the manuscript.

-My only main concern of the study is that the authors very elegantly state in their introduction and conclusion that the benefit of producing this model is to better understand the impact of KTMs on physiology – something that is hard to do in humans. However, other than making very strong claims on the fact that KTMs do not impact overall organismal health, there is very little done to study the benefits of KTMs. Based on what the authors argue is the strength of making this model, this is a glaring weakness. Perhaps the authors could benefit by performing a few physiological assays to determine whether a KTM diet is actually beneficial to some readout of health: healthspan (e.g., motility, gut barrier integrity, etc.), lifespan, stress resilience, etc. I don’t expect the authors to do a comprehensive battery of physiological assays, so this can be minimally addressed by using the RNA-seq analysis to determine whether transcriptional profiles generally associated with increased health/longevity are found to be differentially expressed in their animals.

-The reproduction phenotype is sort of glossed over as being only “minor” effect, but it is still a statistically significant decrease. Generally, a decrease in brood size is considered a negative effect, yet the idea of KTMs is that there is some “health benefit”. The authors really need to address this. Perhaps try to determine why is there a decrease in brood: are the health of the progeny compromised due to the decrease in somatic fat (this can decrease available nutrients given to progeny). Is there a decrease in yolk transmitted to progeny (VIT-2::GFP)? Is this associated with the decrease in germline genes they see?

-The authors should at least comment in text about the decrease in desaturate expression, which is normally correlated with increase in specific fats, yet they see an overall decrease in fats (likely due to the increased expression of other lipases, etc.).

-Is it concerning that the authors see a decrease in neuron-related genes? Is neuronal function affected in these animals (e.g., behavior assays, chemotaxis, etc.)? Again, this can be addressed textually, and I don’t think actual experiments are necessary.

Reviewer #2: Dowen and colleagues present a research study that examines how microbes that are found in kombucha influence C. elegans. I commend the authors on an outstanding study that is well designed and with appropriate experimental controls. I found the manuscript clear to read and appreciate that the data was presented matter-of-factly and not over sold. In light of the popularity of kombucha to the general public, I believe this study will be of general interest beyond the scientific community. Moreover, this work expands upon the list of beneficial microbes that can influence organismal physiology. In my opinion, this work is a perfect fit for PLOS Genetics and can be accepted in its current form. I do note some VERY minor concerns that could help with readability, but these are not required and I leave it to the editor and author if they are helpful.

1. I would encourage the authors to discuss all data points that reach statistical significance in their work as the collectively might contribute to the overall outcomes. This does not require a significant addition to the discussion, but there are several weak phenotypes (but significant) that are not thoroughly accounted for and might be interesting.

2. It would be useful to better exploit the RNAseq data to identify classes of genes that have been found to impact organismal healthspan. These can be done with publicly available tools in WormBase.

Reviewer #3: In this manuscript by DuMez-Kornegay et al., the authors present the findings that consumption of the microbes found in Kombucha Tea, a popular fermented beverage with purported health benefits, by the nematode C. elegans leads to reduction in fat mass. The authors report that reductions in fat mass are accompanied by increases in lysosomal lipase expression and reduced expression of enzymes of fatty acid biosynthesis, leading them to speculate that lipid droplet catabolism by lipophagy is important for the observed changes in overall lipid stores, in parallel with reductions in lipid synthesis.

Major:

Pumping has been shown to be a poor corollary of food intake. At least the authors should acknowledge this; at best they could assess uptake of a vital dye such as C1-BODIPY-C12.

Because of the major intestinal colonization observed with KTM, the authors should test whether the intestine is involuted and/or the luminal volume is expanded. This could be consistent with an increase in autophagic activity and loss of lipid droplets. Also, is the intestine colonized by bacteria or yeast or both?

Pathogen exposure and genetic activation of the stress transcription factor skn-1 have been shown to dramatically reduce somatic fat, much like the effects observed here. The authors should test whether this is a pathogenic response as well as the dependency upon skn-1. The RNAseq data in figure 5 also indicate enrichment of a lipid and pathogen gene expression signature, making this possibility even more likely.

The authors should be sure statistical tests used are indicated in each legend, as well as statistical thresholds (e.g. missing in Fig. 1D).

The lipid quantification by oil red O indicates an extremely small difference in intensity (Y axis scaling should be from 0 not 6.20 to 6.40), whereas the differences seen by Nile red, biochemical quantification, or lipid droplet analysis indicate a much larger effect. The authors should explain the reason for the differences and perhaps consider or explain why the results are so quantitatively discordant.

C. elegans accumulates much more lipid as they transit reproductive life; given that the KTM animals appear smaller, is body size/growth an explanation for the lower fat mass observed? It does not appear to be alterations in time to adulthood based upon data in Fig. 3. The authors should look at later days of adulthood.

Lipid droplet number in addition to size should be included in the analysis in Fig 2/S3, if the analysis was completed properly to objectively quantify lipid droplet number per HPF, for example.

Filter sterilization may not be sufficient to remove all microbes/spores/bacterial products from the KTM-FM mix prior to introduction of the cultured bacteria. This should be addressed, experimentally if possible.

The “wash” experiments in fig 4H-I are informative but don’t entirely say that the small molecules are dispensible; rather they might be important for getting the bacteria to the state where they induce lipid depletion. This possibility should be indicated rather than dismissing the importance of these small molecules. Finally, are the authors certain that the post-fermented mix does not harbor other microbes that proliferated during the fermentation process? If filtration doesn’t completely sterilize the KTM-FM pre-fermentation mix, this could be a possibility. Sequencing could be used to rule this out.

The oil red o data in figure 6G show extremely blunted effect sizes, as above. A more sensitive method should be considered for assessing changes in fat, even though the effects are significant; a 6% difference is of dubious significance (and this appears to be the magnitude based upon the scaling of the axis. Why are the oil-red-o data showing compression of effect size if the effects are really as dramatic as indicated by the lipid droplet reporter and nile red?

The leap from lysosomal lipases to lipophagy is not substantiated and could be speculated in the discussion but should not be indicated in the results. If the authors want to substantiate this claim they should test the requirement of classic autophagy genes, as the effects on lipid levels could be indirect through increased classic oxidation or reduced synthesis. Experiments could be done to indicate increased oxidation (oxygen consumption) or decreased synthesis (e.g. 13C labeling as in Perez and Van Gilst PMID 18762027) but those may be beyond the scope of this investigation. Instead the authors could present the data on expression and functional significance and speculate in the discussion rather than declaratively concluding “lipophagy” as the abstract and results suggest. In contrast the DGAT OE experiment is more convincing, but still the effect size is very small again because of the use of the oil red o assay.

Minor:

Introduction--the authors may want to cite direct consequences of reducing microbial diversity, e.g. C. difficile colitis in response to antibiotics.

Line 61 “hepatoprotective” is not a widely used term, the authors may want to expound on the meaning they intend.

Rather than “standard C. elegans husbandry” the authors may wish to use “Axenic preparation of C. elegans cultures renders…”

The authors may want to specify that NGM-KTM plates contained no antibiotics or antifungals.

Line 224, 225, 228 ab libitum should be ad libitum.

It looks like KTM could disrupt the pulsatility of mlt-10 expression/turnover. Also the KTM data for 3A/B/C appear to be the same without replication and without statistics. How many times was this experiment done and were the results representative? How many animals were counted at each timepoint?

The authors could consider a chi-squared statistic on Figure 3G to show significance.

Did the authors expect to see changes in developmental genes at adulthood (Fig. 3D-F)? Why was an earlier timepoint not queried if differences in development were to be uncovered?

The statement on lines 291-294 is not well justified by the 5xKTM experiment and should be altered or removed.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Revision 1

Attachments
Attachment
Submitted filename: Response_to_Reviews.docx
Decision Letter - Gregory S. Barsh, Editor, Sean P. Curran, Editor

Dear Dr Dowen,

Thank you very much for submitting your Research Article entitled 'Kombucha Tea-associated Microbes Remodel Host Metabolic Pathways to Suppress Lipid Accumulation.' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. All reviewers agree that the authors have addressed the previous concerns. Reviewer 3 has requested some minor corrections to the text, which I believe should be addressed before formal acceptance.  

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by reviewer 3.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Sean P. Curran

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

All reviewers agree that the authors have addressed the previous concerns. Reviewer 3 has requested a some minor corrections to the text, which I believe should be addressed before formal acceptance.

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The authors have done a commendable job in addressing all the comments of the reviewers. The revision is highly improved and this manuscript is a fantastic candidate for PLoS Genetics.

Reviewer #2: The authors have addressed my concerns.

Reviewer #3: The authors for the most part have satisfactorily addressed my concerns. Only a few very minor points and/or errors:

BODIPY staining except at high doses mostly stains gut granules. Many references show this e.g. Yen et al., PlosOne 2020, so the authors may want to adjust the statement 346-352 to indicate that acidified organelles and lipid droplets are illuminated by the BODIPY feeding.

The legend for figure 4J has an error, it does not show images of Calcofluor, and there are 2 “K” references.

Strictly speaking the t-test is not an appropriate statistical test for figure 6A-E and 6J unless it is multiple hypothesis testing corrected. Meanwhile 6K cannot be one way anova because it has only 2 datasets. I suggest the authors look very carefully through their figure assignments and legends one last time.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ryo Higuchi-Sanabria

Reviewer #2: No

Reviewer #3: No

Revision 2

Attachments
Attachment
Submitted filename: Response_to_Reviews.docx
Decision Letter - Gregory S. Barsh, Editor, Sean P. Curran, Editor

Dear Dr Dowen,

We are pleased to inform you that your manuscript entitled "Kombucha Tea-associated Microbes Remodel Host Metabolic Pathways to Suppress Lipid Accumulation." has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Sean P. Curran

Guest Editor

PLOS Genetics

Gregory Barsh

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-23-01118R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Gregory S. Barsh, Editor, Sean P. Curran, Editor

PGENETICS-D-23-01118R2

Kombucha Tea-associated Microbes Remodel Host Metabolic Pathways to Suppress Lipid Accumulation.

Dear Dr Dowen,

We are pleased to inform you that your manuscript entitled "Kombucha Tea-associated Microbes Remodel Host Metabolic Pathways to Suppress Lipid Accumulation." has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Anita Estes

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .